PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY END-USER • Market segmentation by end-user • Comparison by end-user • Pharmaceutical and biotechnology companies - • Market size and forecast 2018-2023 • Academic and research institutions - Market size and forecast 2018-2023 • Others - Market size and forecast 2018-2023 • Market opportunity by end-user PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS • Advances in toxicology • Surge in demand for cosmetics • Increasing investments in drug discovery PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abbott Laboratories • Agilent Technologies Inc. • Bio-Rad Laboratories Inc. • CELTHER POLSKA Sp z o.o. • Charles River Laboratories International Inc. • Eurofins GSC Lux Sarl • Evotec AG • General Electric Co. • Merck KGaA • Thermo Fisher Scientific Inc. PART 14: APPENDIX • Research methodology • List of abbreviations • Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Product overview Exhibit 02: Global healthcare market Exhibit 03: Segments of global healthcare market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: End-user - Market share 2018-2023 (%) Exhibit 19: Comparison by end-user Exhibit 20: Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2023 (%) Exhibit 22: Academic and research institutions - Market size and forecast 2018-2023 ($ millions) Exhibit 23: Academic and research institutions - Year-over-year growth 2019-2023 (%) Exhibit 24: Others - Market size and forecast 2018-2023 ($ millions) Exhibit 25: Others - Year-over-year growth 2019-2023 (%) Exhibit 26: Market opportunity by end-user Exhibit 27: Customer landscape Exhibit 28: Market share by geography 2018-2023 (%) Exhibit 29: Geographic comparison Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 31: North America - Year-over-year growth 2019-2023 (%) Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 33: Europe - Year-over-year growth 2019-2023 (%) Exhibit 34: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 35: Asia - Year-over-year growth 2019-2023 (%) Exhibit 36: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 37: ROW - Year-over-year growth 2019-2023 (%) Exhibit 38: Key leading countries Exhibit 39: Market opportunity Exhibit 40: Impact of drivers and challenges Exhibit 41: Vendor landscape Exhibit 42: Landscape disruption Exhibit 43: Vendors covered Exhibit 44: Vendor classification Exhibit 45: Market positioning of vendors Exhibit 46: Abbott Laboratories - Vendor overview Exhibit 47: Abbott Laboratories - Business segments Exhibit 48: Abbott Laboratories - Organizational developments Exhibit 49: Abbott Laboratories - Geographic focus Exhibit 50: Abbott Laboratories - Segment focus Exhibit 51: Abbott Laboratories - Key offerings Exhibit 52: Agilent Technologies Inc. - Vendor overview Exhibit 53: Agilent Technologies Inc. - Business segments Exhibit 54: Agilent Technologies Inc. - Organizational developments Exhibit 55: Agilent Technologies Inc. - Geographic focus Exhibit 56: Agilent Technologies Inc. - Segment focus Exhibit 57: Agilent Technologies Inc. - Key offerings Exhibit 58: Bio-Rad Laboratories Inc. - Vendor overview Exhibit 59: Bio-Rad Laboratories Inc. - Business segments Exhibit 60: Bio-Rad Laboratories Inc. - Organizational developments Exhibit 61: Bio-Rad Laboratories Inc. - Geographic focus Exhibit 62: Bio-Rad Laboratories Inc. - Segment focus Exhibit 63: Bio-Rad Laboratories Inc. - Key offerings Exhibit 64: CELTHER POLSKA Sp z o.o. - Vendor overview Exhibit 65: CELTHER POLSKA Sp z o.o. - Business segments Exhibit 66: CELTHER POLSKA Sp z o.o. - Organizational developments Exhibit 67: CELTHER POLSKA Sp z o.o. - Key offerings Exhibit 68: Charles River Laboratories International Inc. - Vendor overview Exhibit 69: Charles River Laboratories International Inc. - Business segments Exhibit 70: Charles River Laboratories International Inc. - Organizational developments Exhibit 71: Charles River Laboratories International Inc. - Geographic focus Exhibit 72: Charles River Laboratories International Inc. - Segment focus Exhibit 73: Charles River Laboratories International Inc. - Key offerings Exhibit 74: Eurofins GSC Lux Sarl - Vendor overview Exhibit 75: Eurofins GSC Lux Sarl - Business segments Exhibit 76: Eurofins GSC Lux Sarl - Organizational developments Exhibit 77: Eurofins GSC Lux Sarl - Geographic focus Exhibit 78: Eurofins GSC Lux Sarl - Segment focus Exhibit 79: Eurofins GSC Lux Sarl - Key offerings Exhibit 80: Evotec AG - Vendor overview Exhibit 81: Evotec AG - Business segments Exhibit 82: Evotec AG - Organizational developments Exhibit 83: Evotec AG - Geographic focus Exhibit 84: Evotec AG - Segment focus Exhibit 85: Evotec AG - Key offerings Exhibit 86: General Electric Co. - Vendor overview Exhibit 87: General Electric Co. - Business segments Exhibit 88: General Electric Co. - Organizational developments Exhibit 89: General Electric Co. - Geographic focus Exhibit 90: General Electric Co. - Segment focus Exhibit 91: General Electric Co. - Key offerings Exhibit 92: Merck KGaA - Vendor overview Exhibit 93: Merck KGaA - Business segments Exhibit 94: Merck KGaA - Organizational developments Exhibit 95: Merck KGaA - Geographic focus Exhibit 96: Merck KGaA - Segment focus Exhibit 97: Merck KGaA - Key offerings Exhibit 98: Thermo Fisher Scientific Inc. - Vendor overview Exhibit 99: Thermo Fisher Scientific Inc. - Business segments Exhibit 100: Thermo Fisher Scientific Inc. - Organizational developments Exhibit 101: Thermo Fisher Scientific Inc. - Geographic focus Exhibit 102: Thermo Fisher Scientific Inc. - Segment focus Exhibit 103: Thermo Fisher Scientific Inc. - Key offerings Exhibit 104: Validation techniques employed for market sizing Exhibit 105: Definition of market positioning of vendors

Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., CELTHER POLSKA Sp z o.o., Charles River Laboratories International Inc., Eurofins GSC Lux Sarl, Evotec AG, General Electric Co., Merck KGaA, and Thermo Fisher Scientific Inc.